Ratio Analysis: Unpacking MEDIROM Healthcare Technologies Inc ADR (MRM)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

After finishing at $0.99 in the prior trading day, MEDIROM Healthcare Technologies Inc ADR (NASDAQ: MRM) closed at $0.94, down -5.04%. In other words, the price has decreased by -$5.04 from its previous closing price. On the day, 0.51 million shares were traded. MRM stock price reached its highest trading level at $0.99 during the session, while it also had its lowest trading level at $0.91.

Ratios:

Our goal is to gain a better understanding of MRM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.34.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRM now has a Market Capitalization of 7428623 and an Enterprise Value of 3560677376. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.10. Its current Enterprise Value per Revenue stands at 0.521 whereas that against EBITDA is -25.619.

Stock Price History:

Over the past 52 weeks, MRM has reached a high of $8.39, while it has fallen to a 52-week low of $0.90. The 50-Day Moving Average of the stock is -51.38%, while the 200-Day Moving Average is calculated to be -74.59%.

Shares Statistics:

The stock has traded on average 189.79K shares per day over the past 3-months and 65870 shares per day over the last 10 days, according to various share statistics. Shares short for MRM as of 1730332800 were 40950 with a Short Ratio of 0.31, compared to 1727654400 on 6251. Therefore, it implies a Short% of Shares Outstanding of 40950 and a Short% of Float of 1.38.

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.

Most Popular